Oppenheimer raised the firm’s price target on Nutrien (NTR) to $63 from $58 and keeps an Outperform rating on the shares. The firm remains constructive on Nutrien, with the Q1 shortfall attributed to timing issues. Oppenheimer believes a strong Q2 is now embedded in the outlook, raising the bar. Nutrien delivered a mixed print in Q1 with EBITDA coming in $100M below consensus citing weather shifting Retail volumes from Q1 into Q2, the firm adds.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NTR:
- Nutrien price target raised to $65 from $60 at RBC Capital
- Nutrien price target raised to $59 from $56 at Wells Fargo
- Nutrien’s Stock Performance and Valuation: Hold Rating Amid Limited Upside and Retail Challenges
- Nutrien price target raised to $63 from $62 at Jefferies
- Nutrien’s Q1 2025 Results: Efficiency and Strategic Focus